Gender
Sleep Heart Health Study (SHHS) Visit Number vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 4% oxygen desaturation threshold used or with arousal from type II polysomnography
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Visit 1 | 905 | 21.6 | ± 8.5 | 19.0 | 10.0 | 85.0 | 4,899 | 5,804 |
| Interim Follow-up Visit | - | - | - | - | - | - | - | - |
| Visit 2 | 475 | 20.3 | ± 9.0 | 18.0 | 10.0 | 120.0 | 3,605 | 4,080 |
| CVD Outcomes | - | - | - | - | - | - | - | - |
Age at Sleep Heart Health Study Visit One (SHHS1) vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 4% oxygen desaturation threshold used or with arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 905 | 21.6 | ± 8.5 | 19.0 | 10.0 | 85.0 | 4,899 | 5,804 |
| 35-44 years | 47 | 19.0 | ± 7.0 | 17.0 | 10.0 | 44.0 | 295 | 342 |
| 45-54 years | 120 | 19.4 | ± 6.3 | 18.0 | 10.0 | 41.0 | 897 | 1,017 |
| 55-64 years | 274 | 20.0 | ± 7.2 | 18.0 | 10.0 | 49.0 | 1,495 | 1,769 |
| 65-74 years | 277 | 21.9 | ± 8.8 | 19.0 | 10.0 | 85.0 | 1,340 | 1,617 |
| 75-84 years | 172 | 25.6 | ± 9.8 | 23.0 | 12.0 | 64.0 | 783 | 955 |
| 85 years or older | 15 | 27.3 | ± 6.8 | 28.0 | 13.0 | 37.0 | 89 | 104 |
Gender of the participant vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 4% oxygen desaturation threshold used or with arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 905 | 21.6 | ± 8.5 | 19.0 | 10.0 | 85.0 | 4,899 | 5,804 |
| Male | 618 | 22.6 | ± 8.7 | 20.0 | 10.0 | 85.0 | 2,147 | 2,765 |
| Female | 287 | 19.5 | ± 7.4 | 18.0 | 10.0 | 64.0 | 2,752 | 3,039 |
Gender of the participant vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 4% oxygen desaturation threshold used or with arousal from type II polysomnography
Visit 2
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 475 | 20.3 | ± 9.0 | 18.0 | 10.0 | 120.0 | 3,605 | 4,080 |
| Male | 334 | 21.0 | ± 9.9 | 19.0 | 10.0 | 120.0 | 1,527 | 1,861 |
| Female | 141 | 18.5 | ± 6.0 | 17.0 | 10.0 | 37.0 | 2,078 | 2,219 |
Race of the participant vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 4% oxygen desaturation threshold used or with arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 905 | 21.6 | ± 8.5 | 19.0 | 10.0 | 85.0 | 4,899 | 5,804 |
| White | 785 | 21.8 | ± 8.8 | 19.0 | 10.0 | 85.0 | 4,122 | 4,907 |
| Black | 72 | 20.5 | ± 5.7 | 19.0 | 10.0 | 38.0 | 443 | 515 |
| Other | 48 | 19.9 | ± 6.4 | 19.0 | 10.0 | 41.0 | 334 | 382 |
Race of the participant vs Maximum duration of central apnea in NREM sleep in non-supine position: Central apneas with >= 4% oxygen desaturation threshold used or with arousal from type II polysomnography
Visit 2
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 475 | 20.3 | ± 9.0 | 18.0 | 10.0 | 120.0 | 3,605 | 4,080 |
| White | 433 | 20.3 | ± 9.1 | 19.0 | 10.0 | 120.0 | 3,154 | 3,587 |
| Black | 23 | 19.7 | ± 6.6 | 17.0 | 12.0 | 35.0 | 233 | 256 |
| Other | 19 | 19.6 | ± 9.9 | 17.0 | 11.0 | 49.0 | 218 | 237 |